Skip to main content
. 2018 Dec 3;11:8633–8642. doi: 10.2147/OTT.S186186

Figure 5.

Figure 5

Effect of pectolinarigenin on HCC tumor growth in vivo.

Notes: (A) The tumor mass with or without cabazitaxel treatment. (B) The tumor weight and (C) tumor volume at the end of the experiments were compared in control and cabazitaxel groups. (D) Ki-67 immunohistochemical staining and expression level change (×200) were noted. Data are shown as mean ± SD. *P<0.05 vs control group. The 10 µM Pec indicated 10 µmol/mL pectolinarigenin.

Abbreviation: HCC, hepatocellular carcinoma.